<code id='90BDC6E3DF'></code><style id='90BDC6E3DF'></style>
    • <acronym id='90BDC6E3DF'></acronym>
      <center id='90BDC6E3DF'><center id='90BDC6E3DF'><tfoot id='90BDC6E3DF'></tfoot></center><abbr id='90BDC6E3DF'><dir id='90BDC6E3DF'><tfoot id='90BDC6E3DF'></tfoot><noframes id='90BDC6E3DF'>

    • <optgroup id='90BDC6E3DF'><strike id='90BDC6E3DF'><sup id='90BDC6E3DF'></sup></strike><code id='90BDC6E3DF'></code></optgroup>
        1. <b id='90BDC6E3DF'><label id='90BDC6E3DF'><select id='90BDC6E3DF'><dt id='90BDC6E3DF'><span id='90BDC6E3DF'></span></dt></select></label></b><u id='90BDC6E3DF'></u>
          <i id='90BDC6E3DF'><strike id='90BDC6E3DF'><tt id='90BDC6E3DF'><pre id='90BDC6E3DF'></pre></tt></strike></i>

          focus

          focus

          author:entertainment    Page View:1
          the shape of a medical note connected by dots and lines — health tech coverage from STAT
          Adobe

          In recent months, the federal government has repeatedly told Medicare Advantage insurers that they cannot use artificial intelligence or algorithms to deny medical services the government routinely covers.

          But in finalizing a rule to that effect, it also stepped into a thicket of questions from insurers about a technology that is especially difficult to pin down: What is AI? Can it be used at all to make decisions about the coverage of older patients? If so, how?

          advertisement

          This week, the federal agency that oversees Medicare sought to boil it all down into a simple directive: Put the circumstances of the individual patient first, and your algorithm second.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

          CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

          read more
          ChatGPT in medicine: STAT answers readers' burning questions
          ChatGPT in medicine: STAT answers readers' burning questions

          MikeReddyforSTATArtificialintelligenceisoftendescribedasablackbox:anunknowable,mysteriousforcethatop

          read more
          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more

          Readout Newsletter: The latest from Bristol, Sarepta, and Novartis

          CourtesyBristolMyersSquibbWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetour